Operating Income

Gross Profit

Eli Lilly Gross Profit increased by 1.9% to $16.22B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.4%, from $10.50B to $16.22B. Over 4 years (FY 2021 to FY 2025), Gross Profit shows an upward trend with a 26.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement
SectionOperating Income
CategoryProfitability
SignalHigher is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026

How to read this metric

An increase suggests improved manufacturing efficiency, favorable product mix, or higher pricing power, while a decrease may indicate rising raw material costs, supply chain inefficiencies, or competitive pricing pressure.

Detailed definition

Gross profit represents the residual earnings a company retains after deducting the direct costs associated with produci...

Peer comparison

Peers in the medical device and diagnostics sector typically maintain high gross margins due to intellectual property and specialized manufacturing, though these vary based on the specific product mix of nutritionals versus high-tech devices.

Metric ID: gross_profit

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$4.79B$5.34B$5.95B$5.74B$5.06B$5.36B$5.75B$5.33B$6.50B$7.64B$7.57B$7.09B$9.13B$9.27B$11.13B$10.50B$13.11B$14.59B$15.92B$16.22B
QoQ Change+11.6%+11.4%-3.6%-11.9%+6.0%+7.3%-7.3%+22.0%+17.4%-1.0%-6.2%+28.7%+1.5%+20.1%-5.6%+24.8%+11.3%+9.1%+1.9%
YoY Change+5.7%+0.4%-3.3%-7.1%+28.6%+42.4%+31.5%+33.0%+40.4%+21.3%+47.1%+48.1%+43.6%+57.4%+43.0%+54.4%
Range$4.79B$16.22B
CAGR+29.3%
Avg YoY Growth+30.4%
Median YoY Growth+36.7%
Current Streak4 quarters growth

Frequently Asked Questions

What is Eli Lilly's gross profit?
Eli Lilly (LLY) reported gross profit of $16.22B in Q1 2026.
How has Eli Lilly's gross profit changed year-over-year?
Eli Lilly's gross profit increased by 54.4% year-over-year, from $10.50B to $16.22B.
What is the long-term trend for Eli Lilly's gross profit?
Over 4 years (2021 to 2025), Eli Lilly's gross profit has grown at a 26.7% compound annual growth rate (CAGR), from $21.01B to $54.13B.
What does gross profit mean?
The total revenue earned from sales minus the direct costs required to manufacture and deliver those products.